Suppr超能文献

[2022年至2024年青岛市10至59岁女性自身免疫性甲状腺疾病的流行特征]

[Prevalence characteristics of autoimmune thyroid disease in women aged 10-59 years in Qingdao City from 2022 to 2024].

作者信息

Chen X, Yang J, Guo J, Li S, Liu Z, Zhu Y, Li F, Zhan S, Guo J

机构信息

Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Jun 18;57(3):507-513. doi: 10.19723/j.issn.1671-167X.2025.03.014.

Abstract

OBJECTIVE

To analyze the characteristics of Hashimoto thyroiditis (HT) and Graves disease (GD), two autoimmune thyroid diseases aged 10-59 in Qingdao City from 2022 to 2024, and to provide scientific basis for making targeted prevention and treatment measures.

METHODS

A cross-sectional study design was adopted, based on the data of the Regional Health Information Platform in Qingdao, the confirmed cases of HT and GD from 2022 to 2024 were included, and combined with the data of the seventh population census, the three-year and annual prevalence rates of HT and GD were calculated, and the time trend of annual prevalence was analyzed by Cochran-Armitage trend test. The distribution characte-ristics of HT and GD prevalence in different age groups and regions were analyzed, and Chi-square test was used to compare the differences between the groups.

RESULTS

The total number of HT patients among women aged 10-59 in Qingdao City from 2022 to 2024 was 40 362. The proportion of HT patients in 30- 34 years old was the highest (19.83%). The proportion of HT patients in Huangdao District was the highest (17.72%). The three-year prevalence of HT was 1 206.53/100 000. In 2022-2024, the annual prevalence of HT increased significantly ( < 0.001), from 385.32/100 000 in 2022 to 1 206.32/ 100 000 in 2024. The three-year prevalence of HT was significantly different in age distribution ( < 0.001). The three-year prevalence of HT in 25-29 years (2 354.44/100 000) and 35-39 years (2 022.20/100 000) was higher than that in other age groups, showing a bimodal distribution. There were significant differences in the three-year prevalence of HT in different regions ( < 0.001), among which the three-year prevalence of HT in Shinan District was the highest (2 392.90/100 000), followed by Licang District (1 492.41/100 000), and Laixi City was the lowest (659.940/100 000). The total number of GD patients was 2 095, among which the proportion of GD patients in the 35-39 age group was the highest (15.42%), and the proportion of GD patients from Jimo District was the highest (12.27%). From 2022 to 2024, the three-year prevalence rate of GD was 62.63/100 000, and the annual prevalence rate of GD showed an increasing trend ( < 0.001), from 20.33/100 000 in 2022 to 62.63/100 000 in 2024. There were significant differences in the prevalence of GD by age ( < 0.001). The three-year prevalence of GD reached the highest value in the 25-29 age group (98.90/100 000), followed by the 35-39 age group (85.21/100 000), and the lowest in the 10-14 age group (14.43/100 000). In the regional distribution, there were significant differences in the 3-year prevalence of GD ( < 0.001). Laoshan District had the highest three-year prevalence of GD (107.58/100 000), followed by Shinan District (97.83/100 000) and Huangdao District (28.92/100 000).

CONCLUSION

The three-year pre-valence of HT and GD in females aged 10-59 years in Qingdao City from 2022 to 2024 is low, but the annual prevalence is on the rise, and the three-year prevalence of HT and GD in females aged 25-39 years is higher than that in other age groups, so it is necessary to strengthen the screening and monitoring of this population.

摘要

目的

分析2022年至2024年青岛市10至59岁的两种自身免疫性甲状腺疾病——桥本甲状腺炎(HT)和格雷夫斯病(GD)的特征,为制定针对性的防治措施提供科学依据。

方法

采用横断面研究设计,基于青岛市区域卫生信息平台的数据,纳入2022年至2024年确诊的HT和GD病例,并结合第七次人口普查数据,计算HT和GD的三年患病率和年患病率,采用 Cochr an-Armitage趋势检验分析年患病率的时间趋势。分析HT和GD患病率在不同年龄组和地区的分布特征,采用卡方检验比较组间差异。

结果

2022年至2024年青岛市10至59岁女性中HT患者总数为40362例。30至34岁HT患者所占比例最高(19.83%)。黄岛区HT患者所占比例最高(17.72%)。HT的三年患病率为1206.53/10万。2022年至2024年,HT的年患病率显著上升(<0.001),从2022年的385.32/10万升至2024年的1206.32/10万。HT的三年患病率在年龄分布上有显著差异(<0.001)。25至29岁(2354.44/10万)和35至39岁(2022.20/10万)HT的三年患病率高于其他年龄组,呈双峰分布。HT的三年患病率在不同地区有显著差异(<0.001),其中市南区HT的三年患病率最高(2392.90/10万),其次是李沧区(1492.41/10万),莱西市最低(659.940/10万)。GD患者总数为2095例,其中35至39岁GD患者所占比例最高(15.42%),即墨区GD患者所占比例最高(12.27%)。2022年至

相似文献

5
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.

本文引用的文献

2
Graves disease: latest understanding of pathogenesis and treatment options.格雷夫斯病:发病机制和治疗选择的最新认识。
Nat Rev Endocrinol. 2024 Nov;20(11):647-660. doi: 10.1038/s41574-024-01016-5. Epub 2024 Jul 22.
3
Autoimmune Thyroid Diseases.自身免疫性甲状腺疾病
Semin Nucl Med. 2024 Mar;54(2):219-236. doi: 10.1053/j.semnuclmed.2023.11.002. Epub 2023 Dec 2.
10
Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy.桥本甲状腺炎:流行病学、发病机制、临床与治疗。
Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367. doi: 10.1016/j.beem.2019.101367. Epub 2019 Nov 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验